HistoSonics grabs $40m

HistoSonics, developer of a non-invasive robotic platform and sonic beam therapy, has raised $40 million in Series C-1 financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this